(Q37202848)

18 August 2017

1 reference

title

Treatment of parasitic diarrhea in HIV-infected patients (English)

1 reference

18 August 2017

0 references

Francis Derouin

1

1 reference

18 August 2017

Marie Lagrange-Xelot

series ordinal

2

1 reference

18 August 2017

publication date

1 June 2008

1 reference

Expert Review of Anti-infective Therapy

18 August 2017

published in

1 reference

18 August 2017

volume

6

1 reference

18 August 2017

issue

3

1 reference

18 August 2017

page(s)

337-349

1 reference

Systematic review of strategies to measure HIV-related diarrhea.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Management of protozoa-related diarrhea in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Review: immunologic response to protease inhibitor-based highly active antiretroviral therapy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Sporadic cryptosporidiosis case-control study with genotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Advances in the epidemiology, diagnosis and treatment of cryptosporidiosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Cryptosporidiosis: epidemiology and impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Genetic analysis of Cryptosporidium from 2414 humans with diarrhoea in England between 1985 and 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Zoonotic cryptosporidiosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Cryptosporidiosis: an update in molecular epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Real-time PCR detection and speciation of Cryptosporidium infection using Scorpion probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Rapid microsphere assay for identification of cryptosporidium hominis and cryptosporidium parvum in stool and environmental samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Detection of cryptosporidium and identification to the species level by nested PCR and restriction fragment length polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Case-control study of environmental and social factors influencing cryptosporidiosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Cryptosporidiosis decline after regulation, England and Wales, 1989-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Differences in clinical manifestations among Cryptosporidium species and subtypes in HIV-infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

The impact of HIV-protease inhibitors on opportunistic parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Nitazoxanide: a review of its use in the treatment of gastrointestinal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Application of quantitative real-time reverse transcription-PCR in assessing drug efficacy against the intracellular pathogen Cryptosporidium parvum in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Efficacy of nitazoxanide and paromomycin in biliary tract cryptosporidiosis in an immunosuppressed gerbil model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Nitazoxanide in the treatment of acquired immune deficiency syndrome-related cryptosporidiosis: results of the United States compassionate use program in 365 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Chronic cryptosporidiosis in patients with AIDS: stable remission and possible eradication after long-term, low dose azithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Assessing the microsporidia-fungi relationship: Combined phylogenetic analysis of eight genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Enterocytozoon bieneusi (microsporidia) in clinical samples from immunocompetent individuals in Tenerife, Canary Islands, Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Therapeutic strategies for human microsporidia infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Molecular study of microsporidiosis due to Enterocytozoon bieneusi and Encephalitozoon intestinalis among human immunodeficiency virus-infected patients from two geographical areas: Niamey, Niger, and Hanoi, Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Microsporidiosis in South Africa: PCR detection in stool samples of HIV-positive and HIV-negative individuals and school children in Vhembe district, Limpopo Province

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Intestinal microsporidiosis in human immunodeficiency virus-infected patients with chronic unexplained diarrhea: prevalence and clinical and biologic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

The epidemiology of intestinal microsporidiosis in patients with HIV/AIDS in Lima, Peru

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

New highly divergent rRNA sequence among biodiverse genotypes of Enterocytozoon bieneusi strains isolated from humans in Gabon and Cameroon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Pulmonary localization of Enterocytozoon bieneusi in an AIDS patient: case report and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Microsporidia infection in patients with the human immunodeficiency virus and unexplained cholangitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Laboratory identification of the microsporidia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Development of a real-time polymerase-chain-reaction assay for quantitative detection of Enterocytozoon bieneusi DNA in stool specimens from immunocompromised patients with intestinal microsporidiosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Fumagillin treatment of intestinal microsporidiosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Albendazole for treatment and prophylaxis of microsporidiosis due to Encephalitozoon intestinalis in patients with AIDS: a randomized double-blind controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Inhibitory activity of human immunodeficiency virus aspartyl protease inhibitors against Encephalitozoon intestinalis evaluated by cell culture-quantitative PCR assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Epidemiology of microsporidiosis: sources and modes of transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Quantitative evaluation of the impact of bather density on levels of human-virulent microsporidian spores in recreational water

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Prevalence of intestinal parasites in Cuban acquired immunodeficiency syndrome (AIDS) patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Isosporiasis in patients with HIV infection in the highly active antiretroviral therapy era in France.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Intestinal parasitic infections in Thai HIV-infected patients with different immunity status

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

HIV-associated Isospora belli infection: incidence and risk factors in the French Hospital Database on HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Isospora belli reactive arthritis in a patient with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Isospora belli infection: observation of unicellular cysts in mesenteric lymphoid tissues of a Brazilian patient with AIDS and animal inoculation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Treatment and prophylaxis of Isospora belli infection in patients with the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Diclazuril for Isospora belli infection in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Cyclospora cayetanensis: a review, focusing on the outbreaks of cyclosporiasis in the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Causes of chronic diarrhea in patients with AIDS in Thailand: a prospective clinical and microbiological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Cyclospora cayetanensis, a food- and waterborne coccidian parasite

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Histologic proof of acalculous cholecystitis due to Cyclospora cayetanensis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Detection of Cyclospora cayetanensis oocysts in human fecal specimens by flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

PCR confirmation of infection with Cyclospora cayetanensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Detection of Cyclospora cayetanensis in travellers returning from the tropics and subtropics using microscopy and real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Cyclospora species--a new protozoan pathogen of humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Biliary giardiasis in a patient with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Treatment of patients with refractory giardiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

The activity of protease inhibitors against Giardia duodenalis and metronidazole-resistant Trichomonas vaginalis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Entamoeba histolytica/Entamoeba dispar infections in human immunodeficiency virus-infected patients in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Laboratory diagnostic techniques for Entamoeba species

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Invasive amebiasis: an update on diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Dientamoebiasis: clinical importance and recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Emerging from obscurity: biological, clinical, and diagnostic aspects of Dientamoeba fragilis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Blastocystis in humans and animals: new insights using modern methodologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Blastocystis hominis in human immunodeficiency virus-related diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Blastocystis hominis and the evaluation of efficacy of metronidazole and trimethoprim/sulfamethoxazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Strongyloides hyperinfection syndrome: an emerging global infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Missing infections in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

The changing etiology of chronic diarrhea in HIV-infected patients with CD4 cell counts less than 200 cells/mm3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Rapid increase of mucosal CD4 T cells followed by clearance of intestinal cryptosporidiosis in an AIDS patient receiving highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Indinavir reduces Cryptosporidium parvum infection in both in vitro and in vivo models

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Effect of antiretroviral protease inhibitors alone, and in combination with paromomycin, on the excystation, invasion and in vitro development of Cryptosporidium parvum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Microsporidial keratoconjunctivitis after HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Immune reconstitution disease associated with parasitic infections following initiation of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Prophylaxis with trimethoprim-sulfamethoxazole for human immunodeficiency virus-infected patients: impact on risk for infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Nitazoxanide for persistent diarrhoea in Zambian acquired immune deficiency syndrome patients: a randomized-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Health Sequelae of Human Cryptosporidiosis in Immunocompetent Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Decreased prevalence of intestinal cryptosporidiosis in HIV-infected patients concomitant to the widespread use of protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Effect of Nitazoxanide in Persistent Diarrhea and Enteritis Associated With

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Direct comparison of selected methods for genetic categorisation of Cryptosporidium parvum and Cryptosporidium hominis species

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Invasive amoebiasis: an emerging parasitic disease in patients infected with HIV in an area endemic for amoebic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Possible Effectiveness of Clarithromycin and Rifabutin for Cryptosporidiosis Chemoprophylaxis in HIV Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Examination of extraintestinal tissue cysts of Isospora belli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

Why Does HIV Infection Not Lead to Disseminated Strongyloidiasis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.337

21 January 2018

Identifiers

DOI

10.1586/14787210.6.3.337

1 reference

18 August 2017

1 reference